These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 14702272)

  • 41. A case of aripiprazole and tardive dyskinesia.
    Abbasian C; Power P
    J Psychopharmacol; 2009 Mar; 23(2):214-5. PubMed ID: 18515468
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Ziprasidone-induced hyperprolactinemia: a case report.
    Citil DY; Selçuk E; Karlidağ R; Unal S
    Prog Neuropsychopharmacol Biol Psychiatry; 2008 Apr; 32(3):905-6. PubMed ID: 18276052
    [No Abstract]   [Full Text] [Related]  

  • 43. Neuroleptic drugs and tardive dyskinesia.
    Bittker TE
    Ariz Med; 1981 Sep; 38(9):708-9. PubMed ID: 6117266
    [No Abstract]   [Full Text] [Related]  

  • 44. Possible ziprasidone-induced mania.
    Larson MF; Hauser A
    J Am Acad Child Adolesc Psychiatry; 2003 Sep; 42(9):1012; discussion 1012-3. PubMed ID: 12964565
    [No Abstract]   [Full Text] [Related]  

  • 45. Ziprasidone and mania.
    Barnett MS
    J Am Acad Child Adolesc Psychiatry; 2004 Apr; 43(4):380. PubMed ID: 15187796
    [No Abstract]   [Full Text] [Related]  

  • 46. Ziprasidone-induced hypersensitivity syndrome in an aged schizophrenia patient.
    Tsai CF; Tsai SJ; Hwang JP
    Int J Geriatr Psychiatry; 2005 Aug; 20(8):797-9. PubMed ID: 16035110
    [No Abstract]   [Full Text] [Related]  

  • 47. Ziprasidone-induced hypersensitivity syndrome confirmed by reintroduction.
    Kim MS; Kim SW; Han TY; Son SJ; Lee JH; Kim EJ
    Int J Dermatol; 2014 Apr; 53(4):e267-8. PubMed ID: 24117439
    [No Abstract]   [Full Text] [Related]  

  • 48. Drug-Induced Systemic Hypersensitivity Reaction Associated With Ziprasidone: An Atypical Occurrence.
    Lister JF; Voinov B; Thimothy L; Bean JR
    J Clin Psychopharmacol; 2015 Aug; 35(4):478-80. PubMed ID: 26120944
    [No Abstract]   [Full Text] [Related]  

  • 49. Tardive dyskinesia.
    Murray JB
    Genet Psychol Monogr; 1980 Nov; 102(2):161-90. PubMed ID: 6110612
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Sudden akathisia after a ziprasidone dose reduction.
    Oral ET; Altinbas K; Demirkiran S
    Am J Psychiatry; 2006 Mar; 163(3):546. PubMed ID: 16513883
    [No Abstract]   [Full Text] [Related]  

  • 51. Switching among antipsychotics--focus on side effects.
    Ružić K; Dadić-Hero E; Grahovac T; Sabljić V; Kosec T; Knez R
    Psychiatr Danub; 2011 Mar; 23(1):89-91. PubMed ID: 21448105
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Ziprasidone monotherapy in bipolar II depression: an open trial.
    Liebowitz MR; Salmán E; Mech A; Dunner D; Johnson AE; Akhtar J; Pratap R
    J Affect Disord; 2009 Nov; 118(1-3):205-8. PubMed ID: 19264363
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Mania associated with initiation of ziprasidone.
    Nolan BP; Schulte JJ
    J Clin Psychiatry; 2003 Mar; 64(3):336. PubMed ID: 12716277
    [No Abstract]   [Full Text] [Related]  

  • 54. The highest intentional ziprasidone overdose was not fatal.
    Prieto T; Benabarre A; Bernardo M
    Acta Psychiatr Scand; 2005 Jul; 112(1):79-80; author reply 80. PubMed ID: 15952953
    [No Abstract]   [Full Text] [Related]  

  • 55. Serotonin syndrome caused by ziprasidone alone.
    Lin PY; Hong CJ; Tsai SJ
    Psychiatry Clin Neurosci; 2010 Jun; 64(3):338-9. PubMed ID: 20602736
    [No Abstract]   [Full Text] [Related]  

  • 56. Clinical forms of severe tardive dyskinesia.
    Gardos G; Cole JO; Salomon M; Schniebolk S
    Am J Psychiatry; 1987 Jul; 144(7):895-902. PubMed ID: 2886062
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Screening for tardive dyskinesia.
    Munetz MR; Schulz SC
    J Clin Psychiatry; 1986 Feb; 47(2):75-7. PubMed ID: 2867994
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Follow-up study of 11 patients with potentially reversible tardive dyskinesia.
    Yagi G; Itoh H
    Am J Psychiatry; 1987 Nov; 144(11):1496-8. PubMed ID: 2890309
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Tardive dyskinesia].
    Ruffieux A; Regli F
    Rev Med Suisse Romande; 1985 Apr; 105(4):339-47. PubMed ID: 2861647
    [No Abstract]   [Full Text] [Related]  

  • 60. Ziprasidone and the relative risk of diabetes.
    Vanderburg D; Keohane D; Karayal ON; Pappadopulos E
    Br J Psychiatry; 2011 Feb; 198(2):157-8; author reply 158. PubMed ID: 21282789
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.